Increased platelet reactivity in patients given Orbofiban after an acute coronary syndrome:: An OPUS-TIMI 16 substudy

被引：75
|
作者：
Holmes, MB
Sobel, BE
Cannon, CP
Schneider, DJ
机构：
[1] Univ Vermont, Coll Med, Cardiol Unit, Dept Med, Burlington, VT 05401 USA
[2] Brigham & Womens Hosp, Cambridge, MA USA
[3] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2000年 / 85卷 / 04期
关键词：
D O I：
10.1016/S0002-9149(99)00778-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The results of the present study underscore the potential value of the use of sensitive assays of specific aspects of platelet function for identifying and quantifying changes in platelet reactivity after initiation of therapy with antiplatelet agents. Implementation of such assays could contribute to optimal design and performance of clinical trials of antiplatelet agents as well as treatment of patients with acute coronary syndromes.
引用
收藏
页码：491 / 493
页数：3
相关论文
共 50 条
  • [11] Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial
    Bhadriraju, Satish
    Ray, Kausik K.
    DeFranco, Anthony C.
    Barber, Kim
    Bhadriraju, Padmini
    Murphy, Sabina A.
    Morrow, David A.
    McCabe, Carolyn H.
    Gibson, C. Michael
    Cannon, Christopher P.
    Braunwald, Eugene
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (11): : 1573 - 1577
  • [12] Prognosis and risk stratification of non-obstructive CAD in acute coronary syndrome: observations in TIMI 11B, OPUS-TIMI 16 and PROVE-IT-TIMI 22
    Bugiardini, R.
    Manfrini, O.
    Murphy, S. A.
    De Ferrari, G.
    Braunwald, E.
    Cannon, C. P.
    EUROPEAN HEART JOURNAL, 2005, 26 : 421 - 421
  • [13] Acute Ischemic Heart Disease - Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial
    Smith, CS
    Cannon, CP
    McCabe, CH
    Murphy, SA
    Bentley, J
    Braunwald, E
    AMERICAN HEART JOURNAL, 2005, 149 (03) : 444 - 450
  • [14] White blood cell count, a simple marker of inflammation, is associated with increased mortality in 10,288 patients with acute coronary syndromes in OPUS-TIMI 16
    Cannon, CP
    McCabe, CH
    Wilcox, R
    Bentley, J
    Charlesworth, A
    Braunwald, E
    CIRCULATION, 2000, 102 (18) : 776 - 776
  • [15] Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable Coronary Syndromes-(OPUS-TIMI 16) trial
    Scirica, Benjamin M.
    Cannon, Christopher P.
    Cooper, Richard
    Aster, Richard H.
    Brassard, Jacqueline
    McCabe, Carolyn H.
    Charlesworth, Andrew
    Skene, Allan M.
    Braunwald, Eugene
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 22 (02) : 95 - 102
  • [16] Are there high-risk patients who are troponin negative? further risk stratification with the TIMI risk score in patients with acute coronary syndromes: Results from OPUS-TIMI 16
    Cannon, CP
    McCabe, CH
    Antman, EM
    Bentley, J
    Rifai, N
    Braunwald, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 326S - 326S
  • [17] Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial
    Benjamin M. Scirica
    Christopher P. Cannon
    Richard Cooper
    Richard H. Aster
    Jacqueline Brassard
    Carolyn H. McCabe
    Andrew Charlesworth
    Allan M. Skene
    Eugene Braunwald
    Journal of Thrombosis and Thrombolysis, 2006, 22 : 95 - 102
  • [18] Prior peripheral vascular disease and cerebrovascular disease are independent predictors of increased 1 year mortality in patients with acute coronary syndromes: Results from OPUS-TIMI 16
    Cotter, G
    Cannon, CP
    McCabe, CH
    Charlesworth, A
    Caspi, A
    Braunwald, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 410A - 410A
  • [19] Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
    Cotter, G
    Cannon, CP
    McCabe, CH
    Michowitz, Y
    Kaluski, E
    Charlesworth, A
    Milo, O
    Bentley, J
    Blatt, A
    Krakover, R
    Zimlichman, R
    Reisin, L
    Marmor, A
    Lewis, B
    Vered, Z
    Caspi, A
    Braunwald, E
    AMERICAN HEART JOURNAL, 2003, 145 (04) : 622 - 627
  • [20] G-Protein Beta3 Subunit Polymorphism (GNB3 825T) Carriage is Associated with Increased Bleeding in the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis in Myocardial Infarction (OPUS-TIMI) 16
    Maree, Andrew O.
    Vangjeli, Ciara
    Jneid, Hani
    Cox, Dermot
    Shields, Denis C.
    Fitzgerald, Desmond J.
    CIRCULATION, 2008, 118 (18) : S816 - S816
12345